American Well Corp (AMWL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, American Well Corp (AMWL) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-983.00K) by net assets ($240.12 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See American Well Corp net asset quality index to measure how much of total assets are equity-financed.
American Well Corp - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how American Well Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore American Well Corp long-term investment allocation to see how much of total assets are deployed in long-term investments.
American Well Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of American Well Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
IS:ONCSM
|
0.126x |
|
MOLECULAR PARTNERS ADS/1
F:6ML0
|
-0.139x |
|
Chenghe Acquisition III Co. Class A Ordinary Share
NASDAQ:CHEC
|
-0.001x |
|
Innate Pharma
NASDAQ:IPHA
|
1.078x |
|
Sebo Manufacturing Engineering & Construction Corp
KQ:011560
|
-0.008x |
|
Takarék Jelzálogbank Nyrt
F:FH21
|
-0.130x |
|
BHMINESLTD FPO [BHM]
AU:BHM
|
-0.306x |
|
Oriental Precision & Engineering Co.Ltd
KQ:014940
|
0.088x |
Annual Cash Flow Conversion Efficiency for American Well Corp (2018–2025)
The table below shows the annual cash flow conversion efficiency of American Well Corp from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see American Well Corp stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $247.79 Million | $-65.95 Million | -0.266x | +33.90% |
| 2024-12-31 | $316.24 Million | $-127.34 Million | -0.403x | -30.34% |
| 2023-12-31 | $480.19 Million | $-148.34 Million | -0.309x | -74.10% |
| 2022-12-31 | $1.08 Billion | $-192.32 Million | -0.177x | -58.08% |
| 2021-12-31 | $1.26 Billion | $-141.54 Million | -0.112x | -24.39% |
| 2020-12-31 | $1.25 Billion | $-112.46 Million | -0.090x | +58.68% |
| 2019-12-31 | $374.94 Million | $-81.89 Million | -0.218x | -160.33% |
| 2018-12-31 | $-204.41 Million | $-74.01 Million | 0.362x | -- |
About American Well Corp
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transfor… Read more